Recent studies in healthcare industry have revealed that the introduction of RFID technology does not present any new risk to patients, staff and medical devices.
In recent years, RFID systems have been successfully applied in various industries, such as manufacturing, supply chain, agriculture, transportation, etc. to name a few. However, when it comes to healthcare, managers of healthcare organizations are often skeptical of the technology’s impact on patient safety and RSI errors reduction.
Joining other promising executives selected by EY from around the globe, Xerafy’s Founder & CEO, Dennis Khoo, attended this year’s EY Accelerating Entrepreneurs Program from 21-24 April, along with the Innovation Realized 2018 conference in Amsterdam.
According to EY, The EY Accelerating Entrepreneurs program identifies leading entrepreneurs who show an ability to present new business models and entryways into markets. This year’s class is already solving big challenges, disrupting the markets by applying cutting-edge technologies; the selected entrepreneurs are not only pushing the boundaries of innovation but they are also the next generation of global business leaders.
EY hosted the program in lieu of Innovation Realized 2018 in Amsterdam
Xerafy Healthcare unveiled its award-winning surgical instrument tracking solutions at this week’s IAHCSMM 2018 Annual Conference & Expo held in Phoenix, Arizona, which attracted more than 1,400 Central Sterile Professionals worldwide.
Xerafy team demonstrated its full Surgical Instrument Tracking (SIT) solution to the warm audience, showing how the solution connects all stakeholders in a streamlined workflow, providing each of them with unprecedented visibility at item-level instrument tracking.